Aetna stock: buy or sell?
November 28th, 2018
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions.
Should I buy Aetna stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, 2 buy setups match with Aetna stock right now:
|New all-time high||Yes|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Aetna stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't find any rating for AET stock for the last 30 days.
Aetna stock analysis
After several days of continuous hikes in past weeks, Aetna stayed constant 0.33% to $212.70.
Aetna peaked new all time highs back again on November, marking to $213.36. Shares ended at $212.70 and stayed steady 0.33%. AET shows a sign of strength in the short-term after finally breaking out above $210.90 and marking a new rising bottom. AET price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock.
Shares of Aetna ended this week at $212.70 after topping to a new all time high ($213.36) and jumped a pretty good 3.57%. Early November AET skyrocketed an impressive 5.33% in just one week.
Aetna stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, AET might consolidate in a flat-base, waiting to break out over or down under . Late October 2018 AET price bounced up over the SMA of 20 weeks that acted as support stopping new slides.
Aetna stock price history
Aetna IPO was on January 4th, 2018 at $181.87 per share1. Since then, AET stock surged a 17.00%, with a yearly average of 17.00%. If you had invested $1,000 in Aetna stock in 2018, it would worth $170.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Aetna stock historical price chart
AET stock reached all-time highs on November with a price of $213.36.
Aetna stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not detected any price forecast for Aetna stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAetna presented tiny results for 2018-Q3 . Aetna raised Earnings per Share (EPS) by 4.20%, beating experts estimates of $2.84. Aetna posted $2.96. Aetna is reporting earnings for 2018-Q4 on January. We don't currently have any forecast for next quarter EPS ratio. Keep tuned in the coming weeks to learn about AET's EPS estimate.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2017, Aetna annual revenues slightly fell an awful -4.15% to $60,535.00 M USD from $63,155.00 marked in 2016. When comparing 2017 vs 2016, however, profit margin (that is, the net income divided by revenues) remained stable a -0.45% to 3.15%. Aetna presents anual results in December, and to compare its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Aetna TTM sales up to September 2018 were $61,233.00 and income $3,665.00 M dollars. When comparing this TTM figures with the last reported annuality, we can esteem Aetna business evolution since December 2017: Annual revenues up to September, compared to lastest yearly report, gained a tiny 1.15%. Regarding profit margin, Aetna stepped up 2.84% to 3.15%
|2013||$47,330 M||-||$1,910 M4.0%||-|
|2014||$58,003 M||22.55%||$2,041 M3.5%||6.85%|
|2015||$60,337 M||4.02%||$2,390 M4.0%||17.12%|
|2016||$63,155 M||4.67%||$2,271 M3.6%||-4.99%|
|2017||$60,535 M||-4.15%||$1,904 M3.1%||-16.16%|
|TTM||$61,233 M||1.15%||$3,665 M6.0%||92.49%|
Quarterly financial resultsAetna reported $15,484.00 M in sales for 2018-Q3, a -0.49% decline compared to previous quarter. Reported quarter earnings marked $1,000.00 M with a profit margin of 6.46%. Profit margin decreased a -1.33% compared to previous quarter when profit margin was 7.79%. When comparing turnover to same quarter last year, Aetna sales marked a nice gain and stepped up a 3.27%.
|2016-Q4||$15,750 M||-||$139 M0.9%||-|
|2017-Q1||$15,170 M||-3.68%||$-381 M-2.5%||-374.10%|
|2017-Q2||$15,520 M||2.31%||$1,200 M7.7%||-414.96%|
|2017-Q3||$14,994 M||-3.39%||$838 M5.6%||-30.17%|
|2017-Q4||$14,853 M||-0.94%||$244 M1.6%||-70.88%|
|2018-Q1||$15,335 M||3.25%||$1,209 M7.9%||395.49%|
|2018-Q2||$15,561 M||1.47%||$1,212 M7.8%||0.25%|
|2018-Q3||$15,484 M||-0.49%||$1,000 M6.5%||-17.49%|
Aetna ownershipWhen you are planning to buy shares of a stock, it's worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Aetna, of all outstanding shares are owned by its staff.
The following table compares ownership indicators for other stocks related to Aetna:
|Market cap||$0.0 M|
|Total shares||0.0 M|
|Float shares||0.0 M|
|- Institutional holdings (%)||0.0%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
|Wednesday, November 28th, 2018|
|Day range||$211.79 - $213.36|
|Average true range||$2.52|
|50d mov avg||$203.39|
|100d mov avg||$199.24|
|200d mov avg||$0.00|
Aetna performanceTo measure stock performance is always good to benchmark with competitors or related stocks. We picked as the bechmarking frame for Aetna stock.
Aetna competitorsUnfortunately, we could not find any public company that could be defined as Aetna competitor. This doesn't mean Aetna does not have any competitor in the market, it's just we could not detected it.
Latest Aetna stock news
- InvestorPlaceAetna Uncertainty Is Keeping CVS Stock Way UndervaluedJune 17, 2019
- InvestorPlaceCan CVS Stock Overcome the Latest Wrench in Its Aetna Merger?June 13, 2019
- InvestorPlaceDoes Progress On Aetna Integration Make CVS Health Stock A Buy In May?May 21, 2019
- InvestorPlaceCVS Stock Faces Challenges With Aetna Merger … So Buy It!May 20, 2019
- InvestorPlaceAfter Aetna Merger, The Benefits Outweigh the Risks in CVS StockDecember 3, 2018